• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性阻塞性支气管肺炎中的β受体阻滞剂]

[Beta blocking drugs in chronic obstructive bronchopneumopathies].

作者信息

Durandet P, Gosse P, Vergeret J, Taytard A

机构信息

Service de Pneumologie, Hôpital du Haut-Lévêque, Centre Hospitalo-Universitaire de Bordeaux, Pessac.

出版信息

Rev Mal Respir. 1989;6(2):127-32.

PMID:2567044
Abstract

UNLABELLED

The respiratory tolerance can limit the use of beta-blocker medication (beta-) currently indicated in numerous clinical situations, both cardiovascular and also neurological and ophthalmological. Blockade of beta adrenergic receptors is without risk in subjects free of bronchial pathology, but may destabilize underlying airflow obstruction; either presenting as or sustaining bronchospasm in an asthmatic, and increasing bronchial obstruction, in patients suffering from chronic airflow obstruction (BPCO). Now BPCO, and in particular asthma, are easily associated with diseases for which beta- are indicated. In addition the notion of cardioselectivity is relative and dose dependent.

IN PRACTICE

beta- are contraindicated in chronic airflow obstruction with bronchial hyper-reactivity; in other cases, beta- should be used carefully choosing the most cardioselective products at the lowest effective dose. Whatever the route of administration (in particular eye drops), the beta- are reliable to produce the same harmful effects. There should be strict follow up of treatment and a watch kept for signs of a worsening or a provocation of respiratory problems; conversely the occurrence of such symptomatology in a patient with bronchial pathology should call into question the place of beta-. Finally beta- should be avoided in allergic subjects and (a fortiori) in specific immunotherapy where there is a possibility of anaphylactic shock.

摘要

未标记

呼吸耐受性可能会限制β受体阻滞剂(β-)在目前众多临床情况下的使用,这些临床情况涉及心血管、神经和眼科领域。在没有支气管病变的受试者中,阻断β肾上腺素能受体没有风险,但可能会使潜在的气流阻塞不稳定;在哮喘患者中可能引发或持续支气管痉挛,在患有慢性气流阻塞(慢性阻塞性肺疾病,BPCO)的患者中会加重支气管阻塞。现在,慢性阻塞性肺疾病,尤其是哮喘,很容易与需要使用β-受体阻滞剂的疾病相关联。此外,心脏选择性的概念是相对的且取决于剂量。

实际应用

β-受体阻滞剂在伴有支气管高反应性的慢性气流阻塞中是禁忌的;在其他情况下,应谨慎使用β-受体阻滞剂,选择最具心脏选择性的产品并使用最低有效剂量。无论给药途径如何(特别是眼药水),β-受体阻滞剂都可能产生相同的有害影响。应严格随访治疗情况,并密切关注呼吸问题恶化或引发的迹象;相反,在患有支气管病变的患者中出现此类症状应质疑β-受体阻滞剂的使用。最后,在过敏受试者中应避免使用β-受体阻滞剂,在可能发生过敏性休克的特异性免疫治疗中(更不用说)也应避免使用。

相似文献

1
[Beta blocking drugs in chronic obstructive bronchopneumopathies].[慢性阻塞性支气管肺炎中的β受体阻滞剂]
Rev Mal Respir. 1989;6(2):127-32.
2
beta-Adrenoceptor blockade and pulmonary function in patients suffering from chronic obstructive lung disease.慢性阻塞性肺疾病患者的β-肾上腺素能受体阻滞与肺功能
J Cardiovasc Pharmacol. 1983;5 Suppl 1:S46-50. doi: 10.1097/00005344-198300051-00007.
3
[Bronchial obstruction exacerbated during beta blocker therapy].[β受体阻滞剂治疗期间支气管阻塞加重]
Orv Hetil. 1989 Oct 29;130(44):2365-8.
4
Combination therapy--a review of clinical studies.
Postgrad Med J. 1984;60 Suppl 1:9-12.
5
Experiments on the role of virus infections in the pathogenesis of bronchial asthma. The role of innate or acquired insufficiency or ergotropic adaptation in the mechanism of genesis of bronchial asthma.关于病毒感染在支气管哮喘发病机制中的作用的实验。先天性或后天性不足或应激性适应在支气管哮喘发病机制中的作用。
Allergol Immunopathol (Madr). 1976 Jan-Feb;4(1):15-28.
6
[Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].[慢性阻塞性支气管肺炎患者使用心脏选择性β受体阻滞剂的可能性]
Minerva Med. 1986 Jun 23;77(26):1255-8.
7
[Clinical trials of a new preparation in chronic bronchopneumopathies].[一种新制剂用于慢性支气管肺炎的临床试验]
Minerva Med. 1981 Feb 28;72(7):451-8.
8
[Progestogens in the therapy of chronic obstructive bronchopneumopathies].[孕激素在慢性阻塞性支气管肺病治疗中的应用]
Minerva Med. 1971 Sep 1;62(65):3037-61.
9
Patterns of drug taking in patients with chronic airflow obstruction.慢性气流阻塞患者的用药模式。
Postgrad Med J. 1985 Jan;61(711):7-10. doi: 10.1136/pgmj.61.711.7.
10
[Antihypertensive treatment with beta receptor blockers and obstructive ventilatory disorder (author's transl)].β受体阻滞剂与阻塞性通气障碍的抗高血压治疗(作者译)
MMW Munch Med Wochenschr. 1981 Jul 3;123(27):1119-21.